CARE Stock Analysis: Carter Bank Trust | NASDAQ

Banks - Regional | NASDAQ, USA | Market Cap: 644m USD | 12M Return: 69.2% | US1461031064 | Charts, Fundamentals & Technical Analysis

Deposit Accounts, Commercial Loans, Consumer Loans, Digital Banking
Total Rating 55
Safety 36
Buy Signal -0.13
Regional Banks
Sub-Industry Rotation: +2.9
Market Cap: 644M
Avg Turnover: 5.20M
Risk 3d forecast
Volatility27.8%
VaR 5th Pctl4.53%
VaR vs Median-1.10%
Reward TTM
Sharpe Ratio2.05
Rel. Str. IBD86.7
Rel. Str. Peer Group87.2 pctl
Character TTM
Beta0.431
Beta Downside0.321
Hurst Exponent0.582
Choppyness19.9%
Drawdowns 3y
Max DD31.72%
CAGR/Max DD1.01
CAGR/Mean DD3.35
EPS (Earnings per Share) EPS (Earnings per Share) of CARE over the last years for every Quarter: "2021-09": 0.36, "2021-12": 0.21, "2022-03": 0.36, "2022-06": 0.44, "2022-09": 0.55, "2022-12": 0.62, "2023-03": 0.67, "2023-06": 0.24, "2023-09": 0.2, "2023-12": -0.02, "2024-03": 0.24, "2024-06": 0.21, "2024-09": 0.23, "2024-12": 0.37, "2025-03": 0.32, "2025-06": 0.41, "2025-09": 0.26, "2025-12": 0.41, "2026-03": 0.4, "2026-06": 0.53, "2026-09": 0.35,
EPS CAGR: 38.86%
EPS Trend: 83.4%
Last SUE: -0.15
Qual. Beats: 0
Revenue Revenue of CARE over the last years for every Quarter: 2021-09: 40.52, 2021-12: 37.778, 2022-03: 36.997, 2022-06: 41.906, 2022-09: 46.769, 2022-12: 52.862, 2023-03: 56.211, 2023-06: 47.973, 2023-09: 53.34, 2023-12: 53.199, 2024-03: 58.338, 2024-06: 59.308, 2024-09: 61.128, 2024-12: 60.9, 2025-03: 61.916, 2025-06: 61.664, 2025-09: 63.581, 2025-12: 64.523, 2026-03: 130.159, 2026-06: 90.221, 2026-09: 67.07,
Rev. CAGR: 20.09%
Rev. Trend: 91.8%
Last SUE: 0.59
Qual. Beats: 0

Warnings

Earnings Expected To Drop (P/E To P/E Forward)
Below Avwap Earnings

Tailwinds

Rs Leader

Seasonality 11.9 years of data, until 10/2026

Jan -0.4% 9
Feb -1.2% 4
Mar +0.6% 4
Apr -5.3% 28
May -0.3% 0
Jun +1.4% 4
Jul -0.1% 4
Aug +0.2% 0
Sep -3.5% 14
Oct -2.2% 0
Nov +4.5% 39
Dec +0.0% 0

How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, ≥40 worth a closer look and ≥60 is strong.

Description: CARE Carter Bank Trust

Carter Bankshares, Inc. (NASDAQ: CARE) is a bank holding company that operates Carter Bank & Trust, providing retail and commercial banking products along with insurance services across the United States. The company offers a full suite of deposit products-including checking, savings, retirement, money market accounts, and certificates of deposit-and extends a diverse lending portfolio spanning commercial loans (secured and unsecured, real estate construction, and commercial and industrial loans), consumer loans (auto, home improvement, education, personal, and residential mortgages), home equity lines of credit, and credit cards. Beyond core banking, it provides ancillary services such as safe deposit boxes, direct deposit, debit cards, title insurance, and treasury and corporate cash management solutions, supported by a digital banking platform featuring online and mobile banking, bill payment, mobile deposit, Zelle, and digital wallet integration. Founded in 1974 and headquartered in Martinsville, Virginia, the company went public in August 2012.

As a regional bank operating within the Financials sector, Carter Bankshares follows a traditional community banking model that emphasizes relationship-based lending and deposit gathering, primarily serving small businesses and consumers within its geographic footprint. Regional banks of this size and focus typically derive the bulk of their revenue from net interest income, with non-interest fee services-such as insurance, treasury management, and digital banking tools-serving as supplementary contributors to overall profitability.

Headlines to Watch Out For
  • Net interest margin expands on higher-for-longer rate environment
  • Commercial real estate loan losses pressure credit costs and earnings
  • Deposit costs ease as core funding mix stabilizes
Piotroski VR-10 (Strict) 4.0
Net Income: 130.9m TTM > 0 and > 6% of Revenue
FCF/TA: 0.01 > 0.02 and ΔFCF/TA 0.38 > 1.0
NWC/Revenue: -966.6% < 20% (prev -1.36k%; Δ 394.2% < -1%)
CFO/TA 0.01 > 3% & CFO 57.0m > Net Income 130.9m
Net Debt (-695.2m) to EBITDA (173.3m): -4.01 < 3
Current Ratio: 0.17 > 1.5 & < 3
Outstanding Shares: last quarter (21.8m) vs 12m ago -2.21% < -2%
Gross Margin: 81.32% > 18% (prev 60.71%; Δ 20.61% > 0.5%)
Asset Turnover: 7.35% > 50% (prev 5.13%; Δ 2.23% > 0%)
Interest Coverage Ratio: 1.82 > 6 (EBIT TTM 164.7m / Interest Expense TTM 90.3m)
Altman Z'' -4.02
A: -0.72 (Total Current Assets 715.2m - Total Current Liabilities 4.12b) / Total Assets 4.73b
B: 0.10 (Retained Earnings 483.0m / Total Assets 4.73b)
C: 0.03 (EBIT TTM 164.7m / Avg Total Assets 4.79b)
D: 0.13 (Book Value of Equity 526.9m / Total Liabilities 4.20b)
Altman-Z'' = -4.02 = D
Beneish M -3.61
DSRI: 0.19 (Receivables 17.1m/63.6m, Revenue 352.0m/248.1m)
GMI: 0.75 (GM 60.71% / 81.32%)
AQI: 1.03 (AQ_t 0.83 / AQ_t-1 0.81)
SGI: 1.42 (Revenue 352.0m / 248.1m)
TATA: 0.02 (NI 130.9m - CFO 57.0m) / TA 4.73b)
Beneish M = -3.61 (Cap -4..+1) = AAA
What is the price of CARE shares?

As of November 20, 2026, the stock is trading at USD 28.55 with a total of 232,009 shares traded. Over the past week, the price has changed by -1.89%, over one month by -3.70%, over three months by -7.16% and over the past year by +69.19%.

Current recommended Stop Loss: 27.60 (which is 3.3% or 1.3 ATR below the current price).

Is CARE a buy, sell or hold?

Carter Bank Trust has received a consensus analysts rating of 3.50. Therefore, it is recommended to hold CARE.

  • StrongBuy: 1
  • Buy: 0
  • Hold: 3
  • Sell: 0
  • StrongSell: 0

What are the forecasts/targets for the CARE price?
Analysts Target Price 34.1 19.4%
Carter Bank Trust (CARE) - Fundamental Data Overview as of 17 November 2026
Market Cap USD = 644.2m (644.2m USD * 1.0 USD.USD)
P/E Trailing = 4.9611
P/E Forward = 13.6612
P/S = 2.2505
P/B = 1.2225
Revenue TTM = 352.0m USD
EBIT TTM = 164.7m USD
EBITDA TTM = 173.3m USD
Long Term Debt = 20.0m USD (from longTermDebt, last quarter)
 Short Term Debt = unknown (none)
 Debt = 20.0m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -695.2m USD (calculated: Debt 20.0m - CCE 715.2m)
Enterprise Value = 644.2m USD (floored to Market Cap, CCE > MCap+Debt)
Interest Coverage Ratio = 1.82 (Ebit TTM 164.7m / Interest Expense TTM 90.3m)
EV/FCF = 13.29x (Enterprise Value 644.2m / FCF TTM 48.5m)
FCF Yield = 7.53% (FCF TTM 48.5m / Enterprise Value 644.2m)
FCF Margin = 13.77% (FCF TTM 48.5m / Revenue TTM 352.0m)
Net Margin = 37.19% (Net Income TTM 130.9m / Revenue TTM 352.0m)
Gross Margin = 81.32% ((Revenue TTM 352.0m - Cost of Revenue TTM 65.7m) / Revenue TTM)
Gross Margin QoQ = 53.50% (prev 74.51%)
Tobins Q-Ratio = 0.14 (Enterprise Value 644.2m / Total Assets 4.73b)
 Interest Expense / Debt = 451.7% (Interest Expense 90.3m / Debt 20.0m)
 Taxrate = 20.53% (33.8m / 164.7m)
NOPAT = 130.9m (EBIT 164.7m * (1 - 20.53%))
Current Ratio = 0.17 (Total Current Assets 715.2m / Total Current Liabilities 4.12b)
Debt / Equity = 0.04 (Debt 20.0m / totalStockholderEquity, last quarter 526.9m)
Debt / EBITDA = -4.01 (Net Debt -695.2m / EBITDA 173.3m)
Debt / FCF = -14.34 (Net Debt -695.2m / FCF TTM 48.5m)
Total Stockholder Equity = 497.7m (last 4 quarters mean from totalStockholderEquity)
RoA = 2.74% (Net Income 130.9m / Total Assets 4.73b)
RoE = 26.30% (Net Income TTM 130.9m / Total Stockholder Equity 497.7m)
RoCE = 31.82% (EBIT 164.7m / Capital Employed (Equity 497.7m + L.T.Debt 20.0m))
RoIC = 21.96% (NOPAT 130.9m / Invested Capital 596.0m)
WACC = 6.88% (E(644.2m)/V(664.2m) * Re(7.09%) + (debt cost/tax rate unavailable))
Discount Rate = 7.09% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -90.32 | Cagr: -2.02%
[DCF] Terminal Value 77.97% ; FCFF base≈41.5m ; Y1≈47.6m ; Y5≈70.1m
[DCF] Fair Price = 79.64 (EV 1.05b - Net Debt -695.2m = Equity 1.75b / Shares 22.0m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 83.36 | EPS CAGR: 38.86% | SUE: -0.15 | # QB: 0
Revenue Correlation: 91.82 | Revenue CAGR: 20.09% | SUE: 0.59 | # QB: 0
EPS current Quarter (2027-03-31): EPS=0.57 | Chg30d=-3.39% | Revisions=-40% | Analysts=4
EPS current Year (2026-12-31): EPS=4.88 | Chg30d=-15.38% | Revisions=-40% | GrowthEPS=+250.8% | GrowthRev=+68.6%
EPS next Year (2027-12-31): EPS=2.50 | Chg30d=-3.65% | Revisions=-40% | GrowthEPS=-48.6% | GrowthRev=-21.9%
[Analyst] Revisions Ratio: -67% (up=0, down=6)